Biomedical and biotechnology industry is internationally regarded as the most brilliant star
performer of the future. The development of biomedical depends on a high quality academic
research environment, while innovation and uniqueness should be emphasized for the
development of biotechnology industry. The successful development of biotechnology industry
will be impossible if the development is not based on extensive and in-depth research work
and verification acquired from cl...

DTG 50 milligram (mg) tablet was approved for marketing in Russian Federation; however, DTG
is not currently available for subjects at Acquired Immune Deficiency Syndrome (AIDS) Centers
as it is not available for order and supply via Federal program. This study is an open-label
study which will include subjects, who complete taking DTG in studies ING112276, ING113086,
ING114915, ING111762, and those subjects who end participation in study 200304 in which they
received either DT...

This study is designed to compare the responses to an oral glucose challenge between people
of European and Chinese heritage (essential participants in the European arm must have tow
European parents and likewise for the Chinese participants).

The Programme is focused on adult patients of any gender and age more than 18 y.o., with the
next conditions:
1. Acute cerebrovascular events (ACE, ischemic stroke or intracerebral hemorrhage -
specialty neurology)
2. Acute myocardial infarction (AMI, specialty cardiology)
3. Patients after total hip replacement (THR, specialty orthopaedia) The program is
performed in the in-patient and out-patient rehabilitation departments in 13 regions of
...

The objective of this study is to access retention rate, persistence and adherence in
population of spondylarthritis (SpA) (ankylosing spondylitis (AS) and psoriatic arthritis
(PsA)) participants treated with adalimumab in routine clinical settings in the Russian
Federation.

Born out of the European Union 7th Framework Programme funded project European IPF Network
(eurIPFnet), the European IPF Registry (eurIPFreg) has become Europe's leading database of
longitudinal data from IPF patients, including control groups of patients with other lung
diseases. The registry was initiated with the intention of creating a permanent and
continuously growing record of well defined data on IPF in Europe, in order to increase the
chances of finding better treatmen...

The aim of this study is to generate local data on the safety of Menactra® in individuals 2
to 55 years of age in the Russian Federation.
Primary Objective:
- To describe the safety profile after 1 dose of Menactra® administered in individuals
2-55 years of age under standard health care practices.

The survey try to establish the proportion of patients on lipid-lowering pharmacological
treatment reaching the LDL-C goals according to the Third Joint European Task Force
guidelines, overall and by country.·

The ENSURE study will comprise two phases.
Phase 1: European multicenter survey of surveillance protocols after esophageal cancer
surgery
ENSURE questionnaire will be circulated to representatives from participating European
countries.
Phase 2: European multicenter retrospective observational study of the impact of
postoperative surveillance protocols on oncologic outcome and HR-QL
Phase 2 will constitute a retrospective observational study of patients undergoin...

The objective of this study is to determine utilisation patterns in patients receiving
Angiox® in participating European centres. Additionally, through the collection of
descriptive safety and outcomes data, this study will contribute to the Risk Management
strategy for Europe

The aim of this study is to adapt and validate to the Spanish the European Quality
Questionnaire (EuroQ2) to evaluate families' experiences of quality of care for critically
ill and dying patients in the ICU.

The purpose of this study is to collect additional safety, performance and effectiveness
data of the Easyband gastric band medical device in the treatment of morbid obesity in 4
European countries where the device is a CE marked approved product.

The main objective of EUREST-PLUS is to monitor and evaluate the impact of the Tobacco
Products Directive (TPD) within the context of FCTC ratification at an EU level. The
investigators specific objectives, within WorkPackage 2 and Workpackage 3 are: To evaluate
the psychosocial and behavioral impact of TPD implementation and FCTC implementation,
through the creation of a cohort study of adult smokers in 6 European Member States (EU MS),
Germany, Greece, Hungary, Poland, Romani...

The European Prospective Investigation into Cancer and Nutrition in Norfolk is a population
based prospective study of approximately 25,000 men and women resident in Norfolk United
Kingdom. They were aged 39-79 years when first recruited from general practice age sex
registers at baseline assessment 1993-1997. While part of a ten country half million
participant European collaboration originally aimed to investigate diet and other lifestyle
determinants of cancer, the objective...

Neurocognitive disorders (NCD) are today often largely underdiagnosed or diagnosed in late
stages in France. Indeed the ALzheimer COoperative Valuation in Europe (ALCOVE) study stated
that about 50% of people living with NCD remain undiagnosed until late severe stages with a
deep autonomy loss inducing at risk behaviours and/or behavioural crisis. The French High
Authority of Health (Haute Autorité de Santé - HAS) and ALCOVE recommend a timely diagnosis
at a time when the spe...

Cardiovascular diseases (CVD) are currently the leading cause of death in industrialized
countries and are expected to become the leading cause of death in emerging countries by
20201. According to the official Russian statistics, in 2015, CVD was the cause in 34% of
deaths in Russia2.
Acute Coronary Syndrome (ACS) is the most prevalent manifestation of CVD and is associated
with high mortality and morbidity. No other life-threatening disease is as prevalent or
expensive...

At recent, the number of patients who underwent sedated esophagogastroduodenoscopy has been
on the increase. For such patients, whether topical pharyngeal anesthesia is needed remains
to be controversial. European Society of Gastrointestinal Endoscopy, European Society of
Gastroenterology and Endoscopy Nurses and Associates, and the European Society of
Anaesthesiology Guideline for non-anesthesiologist administration of propofol for GI
endoscopy have not made any recommendation...